Glycom receives Novel Food status for HMO blend
date:Dec 05, 2019
re excited to have received EFSA approval for one more HMO. At Glycom, we continue to expand our HMO portfolio and expect additional HMOs approved shortly. We can now extend our leadership position in the HMO industry, Odd Erik Hansen, CEO at Glycom, tells.

The EC assessed Glycom had sufficiently substantiated the fulfilment for the Novel Food Status requirements. According to Innova Market Insights, the global infant formula market is expected to reach US$79 billion by 2020. The new HMO blend
2/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/08 19:36